Characteristics of exanthemas in adult-onset COVID-19

The aim of the study is to evaluate the frequency and study the features of COVID-19 skin manifestations in adults. Materials and methods. 210 case histories of patients aged 18 to 96 years with confirmed coronavirus infection caused by SARS- CoV-2 virus were analyzed. All patients received standard therapy according to temporary guidelines, and other medications as indicated. Results. Skin manifestations were observed in 11 patients. Rashes appeared in patients in the range from 1 to 10 days from the onset of the disease, while urticary and macular-papular rashes were noted at an earlier time - up to 7 days, and hemorrhagic rashes-on the 5th -10th day. The duration of exanthema ranged from 3 to 14 days, with the longest remaining hemorrhagic elements of the rash. The use of enterosorbents in toxicoderma of infectious and medicinal origin is justified and significantly improves the prognosis. Conclusion. Exanthema was observed in COVID-19 in 5.2% of adult patients. The most frequent was urticarial rash (2.9%) and less - macula-papular 2 (1%) and hemorrhagic-type purpura and vesicles with hemorrhagic content - at the 3 (1.4%). Hemorrhagic elements of the rash were detected in patients with a more severe course. The use of enterosorbents suspends the spread of exanthema, prevents the appearance of new rash elements. Zosterin Ultra 60% is recommended as detoxification and enterosorption therapy for COVID-19, including the development of exanthemums, especially for patients with complaints of constipation that provoke other sorbents.

COVID-19, SARS-CoV-2, hemorrhagic rashes, itching, coronavirus, urticaria, purpura, rash, urticaria, COVID-19, SARS-CoV-2